6851 related articles for article (PubMed ID: 18648558)
1. Whole-body low dose irradiation promotes the efficacy of conventional radiotherapy for cancer and possible mechanisms.
Jin SZ; Pan XN; Wu N; Jin GH; Liu SZ
Dose Response; 2007 Oct; 5(4):349-58. PubMed ID: 18648558
[TBL] [Abstract][Full Text] [Related]
2. Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation.
Wu N; Jin SZ; Pan XN; Liu SZ
Int J Radiat Biol; 2008 Mar; 84(3):201-10. PubMed ID: 18300020
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
Yang W; Li XY
Chin Med J (Engl); 2005 Feb; 118(4):296-301. PubMed ID: 15740667
[TBL] [Abstract][Full Text] [Related]
4. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of pEgr-IL18-B7.2 gene radiotherapy in B16 melanoma-bearing mice.
Yang J; Jin G; Liu X; Liu S
Hum Gene Ther; 2007 Apr; 18(4):323-32. PubMed ID: 17411412
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of pNEgr-mIL-12 recombinant plasmid induced by X-irradiation and its mechanisms.
Yang Y; Liu SZ; Fu SB
Biomed Environ Sci; 2004 Jun; 17(2):135-43. PubMed ID: 15386939
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor effect of pcDNA3. 1-Egr. 1p-p16 gene combined with radiotherapy in tumor-bearing nude mice].
Ma HB; Wang XJ; Hu HT; Di ZL; Xia H; Wang Z; Li C; Han ZK; Ma J; Wu CM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):7-10, 15. PubMed ID: 15871178
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model.
Jin GH; Jin SZ; Liu Y; Xu RM; Yang JZ; Pan XN; Liu SZ
Biochem Biophys Res Commun; 2005 May; 330(3):975-81. PubMed ID: 15809091
[TBL] [Abstract][Full Text] [Related]
10. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
11. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of radiotherapy and endostatin gene therapy in melanoma tumor model.
Wu DS; Wu CM; Huang TH; Xie QD
Radiat Environ Biophys; 2008 Apr; 47(2):285-91. PubMed ID: 18060421
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.
Wu CM; Li XY; Huang TH
World J Gastroenterol; 2004 Oct; 10(20):3011-5. PubMed ID: 15378784
[TBL] [Abstract][Full Text] [Related]
14. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
Yin X; Yan X; Yang Q; Cao H; Liang H
Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
[TBL] [Abstract][Full Text] [Related]
15. Immunologic changes after loco-regional radiotherapy and fractionated total body irradiation (TBI) in mice.
De Ruysscher D; Waer M; Vandeputte M; van der Schueren E
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1237-45. PubMed ID: 2532188
[TBL] [Abstract][Full Text] [Related]
16. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.
Hsieh CT; Luo YH; Chien CS; Wu CH; Tseng PC; Chiou SH; Lee YC; Whang-Peng J; Chen YM
J Immunother; 2016 May; 39(4):153-9. PubMed ID: 27023059
[TBL] [Abstract][Full Text] [Related]
18. [Induction of glutathione and activation of immune functions by low-dose, whole-body irradiation with gamma-rays].
Kojima S
Yakugaku Zasshi; 2006 Oct; 126(10):849-57. PubMed ID: 17016016
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen.
Hillman GG; Reich LA; Rothstein SE; Abernathy LM; Fountain MD; Hankerd K; Yunker CK; Rakowski JT; Quemeneur E; Slos P
J Immunother Cancer; 2017; 5():4. PubMed ID: 28116088
[TBL] [Abstract][Full Text] [Related]
20. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
Wong WW; Mick R; Haraf DJ; Weichselbaum RR; Vokes EE
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):153-62. PubMed ID: 8175423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
